pityriasis%20(tinea)%20versicolor
PITYRIASIS (TINEA) VERSICOLOR
Pityriasis (Tinea) versicolor is a fungal infection caused by Malassezia furfur. It is benign, superficial, and localized to the stratum corneum.
It may present as chronic or recurrent infection and may occur in healthy individuals.
It is more common in summer than winter months.
It presents with multiple well-demarcated macules or patches and finely scaled plaques with hypopigmentation or hyperpigmentation, hence the term "versicolor".
Lesions are usually found on the upper trunk, chest, back and shoulders, and may extend toward the neck, face and arms.
Drug Information

Indication: Cryptococcosis. Systemic, mucosal & vag candidiasis. Prevention of fungal infection in patient w/ malignan...

Indication: Topical treatment of the tinea pedis, tinea cruris, tinea corporis, tinea versicolor, erythrasma candidiasis d...

Indication: Ear drops: Otomycosis. Prophylaxis for swimmers. Lotion: Tinea capitis, tinea barbae, tinea unguium, tinea cor...

Indication: Dermatomycoses, Candida vulvitis & Candida balanitis, pityriasis versicolor, erythrasma.

Indication: Topical fungal infection caused by dermatophytes, yeast, moulds & other fungi including Tinea infections, ...

Indication: Fungal skin infections due to dermatophytes & other dermal infections eg, Tinea pedis, cruris & corpor...

Indication: Topical fungal infection caused by dermatophytes, yeast infection, pityriasis versicolour & cutaneous cand...

Indication: Tinea pedia, tinea cruris & tinea corporis, cutaneous candidiasis & tinea versicolor.

Indication: Topical treatment of tinea corporis, tinea cruris, tinea pedis, pityriasis versicolor & cutaneous candidiasis.

Dezor Plus
ketoconazole + zinc pyrithione

Indication: Topical treatment of seborrheic scalp dermatitis & dandruff.

2  /  9
Editor's Recommendations
Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
Pearl Toh, 6 days ago
Obeticholic acid significantly improves fibrosis and disease activity in patients with nonalcoholic steatohepatitis (NASH), a chronic liver disease currently with no approved therapy, according to an interim analysis of the landmark REGENERATE* study.
Stephen Padilla, 5 days ago
The Lancet Commission on Hypertension Group has recently released a position statement that contains a list of recommendations for the improvement of accuracy standards for devices that measure blood pressure (BP).